ctrl K

Price Alert

Brainstorm Cell Therapeut... (BCLI)

NASDAQ: BCLI · Real-Time Price · USD

0.65

0.04 (6.56%)

At close: Aug 19, 2025, 2:26 PM

0.65

0.00%

After-hours: Aug 19, 2025, 02:26 PM EDT

Brainstorm Cell Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	187K	1.3M	772K	18.86M
Short-Term Investments	n/a	n/a	2.21M	3.24M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	206K	207K	22.99K	26.98K
Receivables	63K	51K	91K	86K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	135K	23K	91K	n/a
Total Current Assets	385K	1.9M	3.11M	23.28M
Property-Plant & Equipment	1.24M	2.1M	5.32M	5.97M
Goodwill & Intangibles	n/a	3K	9.00	17.00
Total Long-Term Assets	1.45M	2.31M	5.34M	6M
Total Assets	1.83M	4.21M	8.45M	29.28M
Account Payables	6.08M	4.95M	6.22M	3.7M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	2.9M	2.85M	1.06M	n/a
Total Current Liabilities	8.98M	7.8M	8.8M	6.32M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	447K	594K	n/a	n/a
Total Long-Term Liabilities	618K	1.27M	2.67M	3.62M
Total Liabilities	9.6M	9.07M	11.47M	9.94M
Total Debt	720K	672K	4.09M	5.08M
Common Stock	n/a	13K	12K	12K
Retained Earnings	-226.64M	-215.01M	-197.82M	-173.54M
Comprehensive Income	n/a	-0.00	0.00	-0.00
Shareholders Equity	-7.76M	-4.86M	-3.02M	19.34M
Total Investments	n/a	185K	2.21M	3.24M